SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-122430 from iBio, Inc. (IBIO)

iBio, Inc.
Date: Nov. 30, 2023 · CIK: 0001420720 · Accession: 0001104659-23-122430

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-275204

Date
November 30, 2023
Author
Felipe Duran
Form
CORRESP
Company
iBio, Inc.

Letter

VIA EDGAR United States Securities Division of Corporation Finance Attention: Tamika Sheppard Re: iBio, Inc. Registration Statement on Form S-1 Filed October 27, 2023 File No: 333-275204

Dear Ms. Sheppard:

iBio, Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-275204), be accelerated by the U.S. Securities and Exchange Commission (the “Commission”) to become effective on Monday, December 4, 2023, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.

The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

The Registrant hereby authorizes Leslie Marlow of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 457-4238 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted.

Very truly yours,
IBIO, INC.

Show Raw Text
CORRESP
1
filename1.htm

November 30, 2023

VIA EDGAR

United States Securities

and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tamika Sheppard

    Re:
    iBio, Inc.

    Registration Statement on Form S-1

    Filed October 27, 2023

    File No: 333-275204

Dear Ms. Sheppard:

iBio, Inc. (the “Registrant”)
hereby requests that the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-275204), be
accelerated by the U.S. Securities and Exchange Commission (the “Commission”) to become effective on Monday, December 4,
2023, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.

The Registrant understands
that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities
under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

The Registrant hereby authorizes
Leslie Marlow of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 457-4238
with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been
granted.

    Very truly yours,

    IBIO, INC.

    By:
    /s/ Felipe Duran

    Name:
    Felipe Duran

    Title:
    Chief Financial Officer

cc:   Leslie Marlow, Blank Rome LLP